Roadmap to successful drug therapy partnerships
Join our upcoming webinar with Cara Begg, Alliance Manager and Dr. Katryn Allen, Director of Business Development at Eurofins Clinical Trial Solutions to discover the comprehensive logistics of sample management and analysis across multiple global clinical trial sites. Our speakers will explore the general timelines and necessary steps from initial lab engagement to final data reporting. Plus, gain insights into regulatory assay requirements and the vital role of reagents in ensuring compliance. Participants will also learn about the needs of custom assay development projects, in support of pre-clinical or clinical studies.
Key learning objectives
- Gain insights into the requirements and challenges of custom assay development
- Discover the benefits of partnering with a central lab for the execution of clinical trials
- Explore the workflow and responsibilities from sample logistics to data reporting
Who should attend?
- Pharma
- Contract research organizations (CROs)
- Translational medicine
- Director of clinical operations
- Bioanalytical scientists
- Project managers and project directors
- Vendor mangers
- Alliance mangers
- Medical monitors
- Clinical research associates (CRAs)
- Clinical Trial Managers (CTMs)
- Associate director bioanalysis and Director bioanalysis
Certificate of attendance
All webinar participants can request a certificate of attendance, including a learning outcomes summary, for continuing education purposes.
Speakers
Cara Begg has worked in the central laboratories industry for 12 years. During this time, she has held roles in both project and alliance management. Her experience includes the management of global multi-site trials and best practices for the successful delivery from set up to close out of the study.
Dr. Katryn Allen has worked for almost a decade in bioanalytical method development, both as a bench scientist and leading a team of senior scientists developing and validating LBA, flow, and cell-based assays. She received her Ph.D. in Toxicology from the University of Kansas Medical Center and has worked as a pre-clinical study director for tox studies.
Moderator
